IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
This study is currently recruiting participants.
Verified April 2017 by National Institute of Allergy and Infectious Diseases (NIAID)
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT01302847
First received: February 15, 2011
Last updated: April 10, 2017
Last verified: April 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Study Completion Date: | No date given |
| Estimated Primary Completion Date: | May 2018 (Final data collection date for primary outcome measure) |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):